Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | MGAM | O43451 | 1/20 | 0.41 |
| ▸ | SI | P14410 | 1/20 | 0.41 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.38 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.38 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.38 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13681841 | 1.00 | GAA (0.45) | GAAKMT2AMEN1MGAMSI | |
| SCHEMBL4819904 | 1.00 | GAA (0.45) | GAAKMT2AMEN1MGAMSI | |
| SCHEMBL9117583 | 0.84 | GAA (0.46) | GAAKMT2AMEN1MGAMSI | |
| SCHEMBL9797359 | 0.84 | GAA (0.46) | GAAKMT2AMEN1MGAMSI | |
| SCHEMBL8917423 | 0.84 | CYP2D6 (0.56) | GAAKMT2AMEN1MGAMSI | |
| SCHEMBL8373589 | 0.83 | MAPT (0.40) | ALDH1A1CYP2D6CYP2C19CHRNB2CHRNB4 | |
| SCHEMBL10747370 | 0.81 | GAA (0.44) | GAAKMT2AMEN1MGAMSI | |
| SCHEMBL12116102 | 0.81 | SMN1; SMN2 (0.50) | ALDH1A1CYP2D6CYP2C19SMN1; SMN2TSHR | |
| SCHEMBL31614616 | 0.80 | ACHE (0.55) | ALDH1A1SMN1; SMN2LMNANPC1RAB9A | |
| SCHEMBL10580487 | 0.80 | ACHE (0.55) | ALDH1A1SMN1; SMN2LMNANPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1697439-B1 | BLOCKED ISOCYANATE CROSSLINKER SOLUTION | VALSPAR SOURCING INC (US) | 2010-11-03 | — | — | EP | claimed |
| EP-1697439-A1 | BLOCKED ISOCYANATE CROSSLINKER SOLUTION | Valspar Sourcing, Inc. (US) | 2006-09-06 | — | — | EP | claimed |
| US-6969754-B2 | Blocked isocyanate crosslinker solution | VALSPAR SOURCING, INC. (US) | 2005-11-29 | — | — | US | claimed |
| WO-2005058998-A1 | BLOCKED ISOCYANATE CROSSLINKER SOLUTION | VALSPAR SOURCING, INC. (US) | 2005-06-30 | — | — | WO | claimed |
| US-20050131193-A1 | BLOCKED ISOCYANATE CROSSLINKER SOLUTION | SWIMC LLC | 2005-06-16 | — | — | US | claimed |
| CN-101597367-B | Preparation method of polyurethane based on vegetable oil and lactic acid | INST PROCESS ENG CAS | 2011-07-27 | — | — | CN | disclosed |
| EP-1697439-B1 | BLOCKED ISOCYANATE CROSSLINKER SOLUTION | VALSPAR SOURCING INC (US) | 2010-11-03 | — | — | EP | disclosed |
| EP-1697439-B1 | BLOCKED ISOCYANATE CROSSLINKER SOLUTION | VALSPAR SOURCING INC (US) | 2010-11-03 | — | — | EP | disclosed |
| CN-101597367-A | A kind of urethane based on vegetables oil and lactic acid and preparation method thereof | INST PROCESS ENG CAS (CN) | 2009-12-09 | — | — | CN | disclosed |
| CN-100523044-C | Blocked isocyanate crosslinker solution | VALSPAR SOURCING INC (US) | 2009-08-05 | — | — | CN | disclosed |
| US-7365174-B2 | Azalide and azalactam derivatives and method for producing the same | MEIJI SEIKA KAISHA, LTD. (JP) | 2008-04-29 | — | — | US | disclosed |
| US-20070042974-A1 | Nozel azalide and azalactam derivatives and method for producing the same | MEIJI SEIKA KAISHA, LTD. (JP) | 2007-02-22 | — | — | US | disclosed |
| WO-2005058998-A1 | BLOCKED ISOCYANATE CROSSLINKER SOLUTION | VALSPAR SOURCING, INC. (US) | 2005-06-30 | — | — | WO | disclosed |
| US-20050131193-A1 | BLOCKED ISOCYANATE CROSSLINKER SOLUTION | SWIMC LLC | 2005-06-16 | — | — | US | disclosed |
| US-20050131193-A1 | BLOCKED ISOCYANATE CROSSLINKER SOLUTION | SWIMC LLC | 2005-06-16 | — | — | US | disclosed |
| EP-1156085-B1 | Binders for use in cathodic electrodeposition coatings, process for their preparation and cathodic electrodeposition coating compositions containing same | DU PONT (US) | 2004-10-06 | — | — | EP | disclosed |
| US-6372108-B1 | Binders for use in cathodic electrodeposition coatings, process for their preparation and cathodic electrodeposition coating compositions containing same | E. I. DU PONT DE NEMOURS AND COMPANY | 2002-04-16 | — | — | US | disclosed |
| EP-1156085-A1 | Binders for use in cathodic electrodeposition coatings, process for their preparation and cathodic electrodeposition coating compositions containing same | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2001-11-21 | — | — | EP | disclosed |
| US-4413010-A | Carbamic acid esters and use as pesticides | HOFFMANN-LA ROCHE INC. (US) | 1983-11-01 | — | — | US | disclosed |
| US-4308184-A | TEXTILES; ADHESION, SOFTNESS, SOLVENT RESISTANCE | BAYER AKTIENGESELLSCHAFT (DE) | 1981-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070042974-A1 | Nozel azalide and azalactam derivatives and method for producing the same | BCL6, NR4A1, NR4A2 | GAA 3793/4885KMT2A 1273/4885MEN1 873/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.